Skip to content

EBIT at other companies

iRadimed logo
iRadimedIRMD
$7.24M+33.2%
Ginkgo Bioworks logo
Ginkgo BioworksDNA
-$71.37M+11.9%
Lifecore Biomedical, Inc. logo
Lifecore Biomedical, Inc.LFCR
-$4.67M-319%
Charles River Laboratories logo
Charles River LaboratoriesCRL
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST

Other financials

Income statement

See full
Revenue$8.0M+11.1%
Gross profit$371.0K-8.2%
Operating income-$13.9M-18.8%
Net income-$14.3M-26.7%
EPS (diluted)-$0.31-19.2%

Balance sheet

See full
Cash & equivalents$14.1M-26.8%
Total debt$23.8M+301%
Total equity$20.4M-68.9%
Total assets$62.4M-27.0%

Cash flow

See full
Operating cash flow-$15.1M-66.1%
CapEx$394.0K+23.5%
Free cash flow-$15.5M-64.7%

Valuation

See full
Market cap$86.19M-43.5%
Enterprise value$95.86M-31.3%
P/S2.5×-2.5×

Profitability

See full
Operating margin-144.2%-12.7pp
Net margin-145.8%-5.0pp
FCF margin-110.5%-14.9pp

Returns & leverage

See full
Return on equity-116.7%-620pp
Debt / equity1.2×+1.1×
Current ratio2.6×-2.0×

Where this comes from

Calculated from Rapid Micro Biosystems’s reported figures.

The official record: Rapid Micro Biosystems’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rapid Micro Biosystems's ebit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Rapid Micro Biosystems's EBIT?
Rapid Micro Biosystems (RPID) reported EBIT of -$13.85M in Q1 2026.
How has Rapid Micro Biosystems's EBIT changed year-over-year?
Rapid Micro Biosystems's EBIT decreased by 18.8% year-over-year, from -$11.66M to -$13.85M.
What is the long-term trend for Rapid Micro Biosystems's EBIT?
Over 4 years (2021 to 2025), Rapid Micro Biosystems's EBIT has grown at a 0.1% compound annual growth rate (CAGR), from -$47.23M to -$47.39M.
What does EBIT mean?
Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.